Statistics from the World Health Organization (WHO) reveal that 12 percent of the Philippine population has asthma, the eleventh leading cause of death in the country.
The most common asthma triggers are dust mites, household pests, mold, and airborne pollen. However, certain illnesses or infections, like a bad cold or a bout with the flu, can also be a factor, especially in adult-onset asthma.
While long-term medications such as inhaled corticosteroids are used to manage asthma symptoms, Covidone TS is an antiseptic spray that offers relief of throat discomforts that asthma sufferers endure. By killing the viruses and bacteria that cause inflammation and infection, Covidone TS, a new brand of povidone-iodine, effectively provides a layer of protection in the throat.
Covidone TS’s efficacy comes from having 0.5 percent povidone-iodine as an active ingredient. With just two sprays into the mouth and throat—4 to 6 times a day—Covidone TS eases pain and swelling and lowers one’s risk for an asthma flare-up.
Nutrana Health and Wellness Co. CEO Ernesto Abad II hopes that, along with colds, flu, and other throat infections, Covidone can give Filipinos a new sense of hope when it comes to dealing with the COVID-19 pandemic.
“That is why we invested our time, effort, and resources in developing Covidone in the middle of the pandemic and making it available as fast as possible so that every Filipino can have that extra layer of protection against infection and feel safe again,” says Abad.
However, as in all over-the-counter (OTC) medications, consumers must ensure that they follow the correct procedure when using Covidone.
Asthma patients can only apply Covidone up to four times a day, with a maximum of 2-3 sprays per use. They must also avoid inhaling the substance.
Parents of asthmatic children must note that Covidone is only safe to use for children aged six years old and above. Kids must spit out any excess Covidone in their mouths, as accidental ingestion may produce adverse effects.